(Total Views: 94)
Posted On: 12/12/2022 11:50:49 AM
Post# of 145209

$PRTA News Article - Prothena Presents Data Demonstrating Consistent Survival Benefit Observed with Birtamimab in Mayo Stage IV AL Amyloidosis Patients in Phase 3 VITAL Study at ASH 2022 https://marketwirenews.com/news-releases/prot...00890.html


My Twitter: WhyteStocks